NPQ — Test, Factor V Leiden Mutations, Genomic Dna Pcr Class II

FDA Device Classification

FDA product code NPQ covers "Test, Factor V Leiden Mutations, Genomic Dna Pcr", a Class II medical device regulated under 21 CFR 864.7280. Submissions are reviewed by the Hematology panel. At least 6 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
NPQ
Device Class
Class II
Regulation Number
864.7280
Submission Type
510(k)
Review Panel
PA
Medical Specialty
Hematology
Implant
No

Definition

In vitro diagnostic test to detect the Factor V Leiden mutation in genomic DNA, as an aid to diagnosis in the evaluation of patients with suspected thrombophilia.

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K100980HologicINVADER FACTOR VJun 1, 2011
K093129IlluminaILLUMINA VERNCODE GENOTYPING TEST FOR FACOR V AND FACTOR IIApr 28, 2010
K093974Osmetech Molecular DiagnosticsESENOR FII-FV-MTHFR GENOTYPING TEST, ESENOR FII-FV GENOTYPING TEST, ESENOR FII…Apr 22, 2010
K082118CepheidXPERT HEMOSIL FACTOR II & FACTOR V ASSAYSep 18, 2009
K060564AutogenomicsINFINITI SYSTEMFeb 7, 2007
DEN030005Roche DiagnosticsFACTOR V LEIDEN KITDec 17, 2003

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.